Fig. 2From: Next generation sequencing to decipher concurrent loss of PMS2 and MSH6 in colorectal cancerIGV view of PMS2 and MSH6 mutations in patient 1. a IGV view of PMS2 R134* mutation in tumour and normal tissue. Variant allelic frequency (VAF) (green) was 50% in both samples. b IGV view of MSH6 c.3261dupC mutation in tumour and normal tissue. VAF was 36% in tumour sampleBack to article page